IONS | Ionis Pharmaceuticals
Category: Science research company
Industry: Drug Manufacturers - Other Quick infos Headquarters: Carlsbad, California, United States Trade prices Volume: Market Cap: 4.4B Prev closed: 46.84 Open: 46.9 High: 47.87 Low: 46.7 52 week low: 41.42 52 week high: 64.37 Dividends: No Dividends Next ER: November 3, 2021 Before Market Opens
About the Company Ionis Pharmaceuticals is a publicly traded pharmaceutical company based in Carlsbad, California, United States.
Earnings History Date EPS / Forecast Revenue / Forecast March 1, 2022 November 3, 2021 -0.58 / -0.5122133M / 158.48MAugust 4, 2021 -0.57 / -0.5548126M / 129.16MMay 5, 2021 -0.64 / -0.5085112M / 128.62MFebruary 24, 2021 -2.44 / 0.2588290M / 274.46MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Nov 26, 2021 29.05 29.86 30.27
28.89
755.72K -2.39% Nov 24, 2021 29.76 29.80 29.94
28.75
1.30M -1.88% Nov 23, 2021 30.33 30.56 30.80
29.66
1.64M -1.04% Nov 22, 2021 30.65 32.37 32.37
30.57
1.21M -4.19% Nov 19, 2021 31.99 32.14 32.35
31.42
927.47K -0.47% Nov 18, 2021 32.14 33.49 33.77
31.96
927.43K -1.05% Nov 17, 2021 32.48 32.47 32.74
31.59
916.05K -0.58% Nov 16, 2021 32.67 32.90 33.01
32.37
692.17K -0.37% Nov 15, 2021 32.79 32.96 33.29
32.70
627.69K 0.31% Nov 12, 2021 32.69 33.67 33.67
32.61
404.20K -2.59% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US4643301090 CUSIP: 464330109 Founded:1989 Employees:435 News
Why Akcea Therapeutics Stock Skyrocketed Today fool.com Apr 7, 2021 7:44 pm
Are Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? finance.yahoo.com Apr 7, 2021 10:04 am
Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com Apr 7, 2021 8:25 am
Ionis (IONS) Crashes as Roche-Partnered Huntington's Drug Fails finance.yahoo.com Apr 7, 2021 8:09 am
Ionis to present at upcoming investor conferences finance.yahoo.com Apr 7, 2021 7:05 am
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS finance.yahoo.com Apr 7, 2021 7:05 am
Ionis reports third quarter 2020 financial results and recent business achievements finance.yahoo.com Apr 7, 2021 7:00 am Ionis announces proposed private placement of convertible ... prnewswire.com Apr 7, 2021 5:34 am Ionis proposes private placement of $500M of convertible notes seekingalpha.com Apr 7, 2021 4:48 am Premarket Movers Tuesday - GameStop, Baidu, ViacomCBS, Ionis thestreet.com Apr 7, 2021 4:17 am
WAYLIVRA® (volanesorsen), the First and Only Therapy for Familial Chylomicronaemia Syndrome, an Ultra-Rare and Life-Threatening Condition, to Be Available on the NHS in Scotland finance.yahoo.com Apr 7, 2021 3:00 am Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy finance.yahoo.com Apr 7, 2021 12:34 am Ionis Antisense Oligonucleotides To Be Evaluated With Progenity's Drug Delivery System finance.yahoo.com Apr 6, 2021 10:34 pm Progenity and Ionis ink collaboration agreement seekingalpha.com Apr 6, 2021 8:07 pm Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Ionis Pharmaceuticals, Inc. (IONS) Investigation finance.yahoo.com Apr 6, 2021 2:34 pm Introducing Ionis Pharmaceuticals (NASDAQ:IONS), A Stock ... simplywall.st Apr 6, 2021 2:34 pm Ionis initiates rare neurodegenerative disorder late-stage study seekingalpha.com Apr 5, 2021 9:02 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS finance.yahoo.com Mar 31, 2021 11:07 pm SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ... prnewswire.com Mar 31, 2021 2:34 pm
Biotech Stock Roundup: REGN Cocktail Data Positive, INCY's Jakafi Disappoints & More finance.yahoo.com Mar 24, 2021 3:43 pm This company doesn't provide a dividend.
Key Persons CEO : Stanley T. Crooke, MD, PhD Talk about Ionis Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
